These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28526094)

  • 1. Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study.
    Courjon J; Demonchy E; Degand N; Risso K; Ruimy R; Roger PM
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):40. PubMed ID: 28526094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach of empirical antibiotic treatment: analyzing bacterial resistance of community-acquired bacteremia.
    Young TG; Chen YS; Yen MY
    J Microbiol Immunol Infect; 2010 Feb; 43(1):43-6. PubMed ID: 20434122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin/clavulanic acid+aminoglycoside as empirical antibiotic treatment in severe community-acquired infections with diagnostic uncertainty.
    Courjon J; Chirio D; Demonchy E; Michelangeli C; Degand N; Roger PM
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):895-901. PubMed ID: 30707379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
    Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
    BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Community-acquired bacteremia].
    Cisterna R; Cabezas V; Gómez E; Busto C; Atutxa I; Ezpeleta C
    Rev Esp Quimioter; 2001 Dec; 14(4):369-82. PubMed ID: 11856984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection.
    Lau SM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2004 Jun; 37(3):185-91. PubMed ID: 15221039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETIOLOGY AND RESISTANCE PROFILE OF ISOLATED STRAINS FROM SEVERE SYSTEMIC INFECTIONS IN PATIENTS WITH IMMUNODEPRESSION--EXPERIENCE OF THE IASI INFECTIOUS DISEASES HOSPITAL 2011-2014.
    Pleşca CE; Luca MC; Luca AS; Constantinescu S; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1141-6. PubMed ID: 26793861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremia in children at a regional hospital in Trinidad.
    Orrett FA; Changoor E
    Int J Infect Dis; 2007 Mar; 11(2):145-51. PubMed ID: 16787754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance profiles and risk factors of resistant microorganisms in bacteraemia of abdominal origin.
    Martín Jaramago J; Armero Ibáñez R; Camarena Miñana JJ; Morales Suárez-Varela M
    Rev Esp Anestesiol Reanim; 2017 Nov; 64(9):490-498. PubMed ID: 28434558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department.
    Chiu CW; Li MC; Ko WC; Li CW; Chen PL; Chang CM; Lee NY; Lee CC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):92-100. PubMed ID: 24060496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the management of 493 patients presenting with bacteremia in 23 northern French hospitals.
    Alfandari S; Cabaret P; Nguyen S; Descamps D; Vachée A; Cattoen C; Van Grunderbeeck N;
    Med Mal Infect; 2016 Jun; 46(4):194-9. PubMed ID: 27132208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
    Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of community-acquired bacteremia among infants in a medical center in Taiwan, 2002-2011.
    Ting YT; Lu CY; Shao PL; Lee PI; Chen JM; Hsueh PR; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2015 Aug; 48(4):413-8. PubMed ID: 24291617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
    Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
    Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcome of elderly patients with community-onset bacteremia.
    Hernández C; Fehér C; Soriano A; Marco F; Almela M; Cobos-Trigueros N; De La Calle C; Morata L; Mensa J; Martínez JA
    J Infect; 2015 Feb; 70(2):135-43. PubMed ID: 25224642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-drug resistance and high mortality associated with community-acquired bloodstream infections in children in conflict-affected northwest Nigeria.
    Chukwumeze F; Lenglet A; Olubiyo R; Lawal AM; Oluyide B; Oloruntuyi G; Ariti C; Gomez D; Roggeveen H; Nwankwo C; Augustine NA; Egwuenu A; Maloba G; Sherlock M; Muhammad S; Wertheim H; Hopman J; Clezy K
    Sci Rep; 2021 Oct; 11(1):20814. PubMed ID: 34675262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical characteristics and outcomes of patients with community acquired bacteremia caused by Escherichia coli, Burkholderia pseudomallei and Staphylococcus aureus: A prospective observational study (Ubon-sepsis).
    Somayaji R; Hantrakun V; Teparrukkul P; Wongsuvan G; Rudd KE; Day NPJ; West TE; Limmathurotsakul D
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009704. PubMed ID: 34478439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos.
    Phetsouvanh R; Phongmany S; Soukaloun D; Rasachak B; Soukhaseum V; Soukhaseum S; Frichithavong K; Khounnorath S; Pengdee B; Phiasakha K; Chu V; Luangxay K; Rattanavong S; Sisouk K; Keolouangkot V; Mayxay M; Ramsay A; Blacksell SD; Campbell J; Martinez-Aussel B; Heuanvongsy M; Bounxouei B; Thammavong C; Syhavong B; Strobel M; Peacock SJ; White NJ; Newton PN
    Am J Trop Med Hyg; 2006 Nov; 75(5):978-85. PubMed ID: 17124000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and impact of empirical therapy in cirrhotic adults with community-onset bacteremia.
    Hsieh CC; Lee CC; Chan TY; Hong MY; Chi CH; Ko WC
    Am J Emerg Med; 2015 Feb; 33(2):222-8. PubMed ID: 25498529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.